Clinical Trials Browser

Interventional × Nadroparin × Clear all

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Prostatic Neoplasms, Venous Thrombosis

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

56 enrolled

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Phase NA Completed

362 enrolled

Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

NCT01980849 2013-11-21

LCAN

Phase 3 Unknown

272 enrolled

Thoracic

Lung Neoplasms

NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Phase 3 Completed

1,166 enrolled

Neoplasm Metastasis, Neoplasms, Thromboembolism

Clinical Trials

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Longheva

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

LCAN

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)